2450 Holcombe Boulevard
About SaranasSaranas is a privately held Houston, Texas-based medical device company focused on improving patient outcomes through early detection of internal bleeding complications.
Founder and CMO: Mehdi Razavi
CEO: Zaffer Syed
CFO: Greg Guidroz
Tweets by Saranas
12 articles with Saranas
Novel technology offers physicians first and only real-time detection and monitoring of endovascular bleed complications
Saranas, Inc. announced the commercial launch of the Early Bird Bleed Monitoring System in the United States.
Saranas Inc. announced that it has been named one of Houston’s most innovative companies.
A recent report by CBRE Research analyzing U.S. life science clusters, found that Houston, Texas is the third-fastest growing life science market from 2014 to 2017. One doesn’t typically think of Texas, let alone Houston, as being a center for the life sciences. Oil, energy and tech, yes, but not...
First In Human Experience to be Presented at TCT 2018
Saranas Inc. has been invited to present at the Transcatheter Valve Therapies (TVT) Structural Heart Disease Summit
Saranas Inc., today announced the completion of a $2.8 million Series C funding round.
Saranas Inc. announced that it has submitted to the U.S. Food and Drug Administration (FDA) an application requesting Agency review and de novo classification of the Early Bird Bleed Monitoring System.
Saranas’ Novel Bleed Monitoring System Receives Recognition in Cardiovascular Research Technologies 2018 Competition
Saranas placed first runner-up at the Cardiovascular Research Technologies (CRT) competition on March 6, 2018, in Washington, D.C.
Saranas has been invited to present at the 21st Cardiovascular Research Technologies (CRT18) annual conference, March 6, 2018, in Washington, DC.
Saranas Raises $4 Million To Advance New Device For Real-Time Detection Of Internal Bleeding During Cardiac Procedures